Clinical Trial Update: Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing olmesartan medoxomil with losartan in elderly patients with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BENICAR (OLMESARTAN MEDOXOMIL)
• Cozaar (losartan)

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED